Coalescence Pharmaceuticals Private Limited
About Coalescence Pharmaceuticals Private Limited
Data last updated:
Coalescence Pharmaceuticals Private Limited was a private limited company based in Howrah, West Bengal, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the retail trade segment of the trading and commerce sector. It was incorporated on 02 September 2011.
The company was registered with the Registrar of Companies (ROC), Kolkata, under CIN U85100WB2011PTC167099.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Deepak Kumar Singh and Shrikanta Singh.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Unit No.302 3rd Floor Forum Rangoli Mall 212 Girish Ghosh Road Belurmath, Howrah, West Bengal, India – 711202.
As per the financials filed for FY 2017, the company reported a revenue of ₹15,750. For the same year it recorded a net profit of ₹1,122 (net margin 7.1%) and EBITDA of -₹14,128 (EBITDA margin -89.7%).
Company details
Contact details
Coalescence Pharmaceuticals Private Limited's registered office is in Howrah, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No.302 3rd Floor Forum Rangoli Mall 212 Girish Ghosh Road Belurmath, Howrah, West Bengal, India – 711202
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Coalescence Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Coalescence Pharmaceuticals Private Limited
FY 2019 filings availableCoalescence Pharmaceuticals Private Limited reported revenue of ₹15,750 for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹15,750 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹14,128 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1,122 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -89.7% | ||
| Net Profit Margin | 7.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Coalescence Pharmaceuticals Private Limited, buy the company report.
Board of directors of Coalescence Pharmaceuticals Private Limited
Coalescence Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar Singh Also directs: Vairagi Breweries Private Limited, Aristo Realtors Private Limited, Shivaangan Marketing Private Limited and 2 more | Director | 02 Sep 2011 | 15 Years 2 Months | As last reported |
| Shrikanta Singh | Director | 18 Jun 2012 | 14 Years 4 Months | As last reported |
| Bhrighu Nath Singh | Director | 02 Sep 2011 | 15 Years 2 Months | As last reported |
Auditor
Coalescence Pharmaceuticals Private Limited is audited by S.K. GOSWAMI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.K. GOSWAMI & ASSOCIATES | FY 2017 | 063792 |
Shareholding
The shareholding of Coalescence Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Coalescence Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Coalescence Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Coalescence Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Coalescence Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Coalescence Pharmaceuticals Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Shrikanta Singh was appointed as Director on 18 Jun 2012.
Frequently asked questions
Coalescence Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Coalescence Pharmaceuticals was a private limited company based in Howrah, West Bengal, India. The company worked in retailers, within the trading industry. It was incorporated on 02 September 2011 and is registered under CIN U85100WB2011PTC167099. The company has been struck off by the Registrar of Companies and is no longer operational.
Coalescence Pharmaceuticals had 3 directors:
- Deepak Kumar Singh - Director
- Shrikanta Singh - Director
- Bhrighu Nath Singh - Director
The CIN (Corporate Identification Number) of Coalescence Pharmaceuticals is U85100WB2011PTC167099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Coalescence Pharmaceuticals is at Unit No.302 3rd Floor Forum Rangoli Mall 212 Girish Ghosh Road Belurmath, Howrah, West Bengal, India – 711202.
Coalescence Pharmaceuticals was incorporated on 02 September 2011. It is registered with the Registrar of Companies, Kolkata.
The latest financial statements of Coalescence Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
Coalescence Pharmaceuticals operated in the trading industry, in the retailers segment. It worked in this industry before it was struck off.
Shrikanta Singh was appointed as Director on 18 Jun 2012. Bhrighu Nath Singh was appointed as Director on 02 Sep 2011. Deepak Kumar Singh was appointed as Director on 02 Sep 2011.
The compliance status of Coalescence Pharmaceuticals is compliant as of 20 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
